Adaptive Biotechnologies ADPT Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's operating lease liabilities (current)?
- Adaptive Biotechnologies (ADPT) reported operating lease liabilities (current) of $8.51M in Q1 2026.
- How has Adaptive Biotechnologies's operating lease liabilities (current) changed year-over-year?
- Adaptive Biotechnologies's operating lease liabilities (current) decreased by 18.6% year-over-year, from $10.46M to $8.51M.
- What is the long-term trend for Adaptive Biotechnologies's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's operating lease liabilities (current) has grown at a 20.4% compound annual growth rate (CAGR), from $3.53M to $8.92M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.